SynVent

SynVent is a proprietary platform designed to facilitate fully integrated therapeutic drug discovery and development. It supports a wide range of projects involving small molecules, new modalities, and biologics, offering comprehensive assistance from the initial concept to clinical stages.

The platform provides a seamless execution of drug discovery programs, allowing for a smooth transition from discovery to development. SynVent's team, composed of experienced professionals from biotech and pharma sectors, offers expertise in synthetic and medicinal chemistry, biology, DMPK, and toxicology. This ensures that projects have a clear translational path to clinical efficacy.

SynVent acts as a one-stop solution for managing and coordinating drug discovery projects. It allows clients to focus on key milestones and core scientific needs while benefiting from extensive drug discovery knowledge and project management skills.

Key Features:

• Integrated support from concept to clinic for drug discovery projects.
• Expertise in small molecules, new modalities, and biologics.
• Seamless integration of synthetic and medicinal chemistry, biology, DMPK, and toxicology.
• Experienced team with decades of industry experience.

Testimonials from clients highlight the platform's scientific excellence, project team spirit, and high productivity levels. Clients have successfully collaborated with SynVent on various projects, including neuroscience programs and anti-cancer therapy development, benefiting from the platform's collaborative and flexible approach.

Overall, SynVent offers a comprehensive and integrated approach to drug discovery, making it an ideal partner for both modest biotech firms and large pharmaceutical companies.